Vanina de Verneuil, EVP, General Counsel, Corporate Secretary at Vir Biotechnology, Inc. (VIR), sold 3,750 shares at $11.33 ($42K) on 2026-11-02, disclosed to the SEC on 2026-11-04.
Scheduled sale ($42k) by EVP, General Counsel, Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.33 | 1,343 | $15K | 36.3% |
| 2 | $11.10 | 2,407 | $27K | 63.7% |
| Total | $11.18 avg | 3,750 | $42K | 100% |
| Filing → |
| VIR | SELL | 2025-11-07 | $12K | — | Filing → |
| VIR | SELL | 2025-11-04 | $8K | — | Filing → |
| VIR | SELL | 2025-02-27 | $135K | — | Filing → |